Brief: SynAct Pharma Board, Management Enter Lock-Up Agreements
Dec 23 (Reuters) - SynAct Pharma AB SYNACT.ST: BOARD OF DIRECTORS AND MANAGEMENT ENTER LOCK-UP AGREEMENTS LOCK-UP AGREEMENTS FOR SHARES AND/OR OTHER SECURITIES IN COMPANY UNTIL AND INCLUDING JUNE 30, 2026. LOCK-UP PREVENTS TRANSFER OR DISPOSAL OF SHARES AND/OR OTHER SECURITIES IN COMPANY, WITH CUSTOMARY EXCEPTIONS Source text: ID:nMFNbw4khM Further company coverage: SYNACT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026